Haryana, India

Kirti Bajaj

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Vyome Biosciences Pvt. Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kirti Bajaj. Retrieved from https://idiyas.com/inventor/kirti-bajaj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kirti Bajaj: Innovator in Antifungal and Antibacterial Prodrugs

Introduction

Kirti Bajaj is a notable inventor based in Haryana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of conjugate-based antifungal and antibacterial prodrugs. His innovative work aims to enhance the efficacy of existing treatments for fungal and bacterial infections.

Latest Patents

Kirti Bajaj holds a patent for his invention titled "Conjugate-based antifungal and antibacterial prodrugs." This invention provides a novel approach by forming prodrugs through the coupling of at least one antifungal or antibacterial agent with a linker and/or carrier. The prodrugs are represented by specific formulas that include various components such as antifungal agents, carriers, and linkers. Additionally, the invention encompasses nanoparticles that comprise these conjugate-based prodrugs, as well as non-conjugated antifungal and antibacterial agents in nanoparticle form.

Career Highlights

Kirti Bajaj is currently associated with Vyome Biosciences Pvt. Ltd., where he continues to work on innovative solutions in the pharmaceutical sector. His research and development efforts focus on creating effective treatments that can combat resistant strains of pathogens.

Collaborations

Some of his notable coworkers include Abhijit S Bapat and Gauthami Mahesh, who contribute to the collaborative efforts in advancing the company's research initiatives.

Conclusion

Kirti Bajaj's work in developing conjugate-based antifungal and antibacterial prodrugs represents a significant advancement in the pharmaceutical industry. His innovative approach and dedication to research continue to pave the way for new treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…